Nucletron BV and Elekta renew and expand distribution agreement for PreciseSIM® simulator systems and related services

August 13 2003  

Veenendaal, 13^th August 2003 – Nucletron BV has announced that it has renewed its worldwide distribution agreement with Elekta for providing simulator systems. These simulators are sold by Elekta under the trade name PreciseSIM^® and incorporate Elekta’s Precise Table. The renewed agreement, which runs for 5 years, means an expansion of Nucletron’s business with Elekta, as Nucletron will be providing installation and maintenance services for PreciseSIM^®.


“The renewed agreement will further strengthen the already successful partnership with Elekta, which started in 1998. Nucletron will now take on the installation and service activities for PreciseSIM^®, which ensures Elekta long term access to high quality simulator solutions for their customers.” said Rudolf Scholte, CEO of Nucletron. “Our renowned Simulix^® simulator products have established our leading position around the world with over 1,000 installed systems, and we continue to invest in technology like the digital flat panel detector incorporated in our new Simulix EVOLUTION™ simulator. This relationship will continue Nucletron’s access to all sectors of the market and represents a significant expansion of our service related activities.”


“By combining our Precise Table with the Nucletron system our customers get reproducibility between simulation and treatment, together with the high image quality available from a conventional simulator” noted Jill Stief, Product Manager for Imaging and Positioning at Elekta. “PreciseSIM^® is an exceptionally easy to use system with a full complement of clinical features all packaged in a system that is has superb stability and precision”


“The alliance with Nucletron is a key part of our strategy to offer a complete range of solutions to our customers” stated Dee Mathieson, Vice President of Product Management at Elekta.“ This philosophy extends from product through to service. Partnering with Nucletron for the provision of service and installation will ensure the skills and resources are available to offer our customer base the high level of support they expect. The agreement will also offer access to emerging simulation technology, such as solid state imaging, which will compliment our innovative imaging portfolio”.


Nucletron specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in brachytherapy, treatment planning, information management and simulation. The company has 20 offices worldwide, including its corporate headquarters in The Netherlands.


Nucletron® B.V. is a subsidiary of Delft Instruments N.V.( http://www.delftinstruments.com/ ). Delft Instruments employs some 1,200 people, is listed on Euronext Amsterdam and is included in the NextEconomy segment. The company reported net profit of EUR 10.9 million on turnover of EUR 194 million in 2002. For more information on Nucletron®, please visit: http://www.nucletron.com/.


Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta^® solutions are clinically effective, cost efficient and gentle on the patient. For more information on Elekta visit www.elekta.com

For further information, please contact: